Kevin M Moriarty

Director Kevin M Moriarty buys 3,955 shares (4.0K) at $12.64 as stock down 53.8% from 52-week high.

Director Kevin M Moriarty purchased 3,955 shares for $50,000.40 on 2026-05-26 at $12.64, increasing his holdings to 71,010 shares. The purchase occurs in a context of significant deterioration: the stock is -53.8% from its 52-week high of $25.93, down 20.3% over the past 30 days and 46.6% over 90 days, while the company reported $0 revenue in the latest quarter, a net loss of $-235,000,000, and annual revenue contraction of 85.8%. Moriarty's cross-ticker track record shows 1 prior buy with a 100.00% 90-day win rate and average 90d return of 8.0%, though this limited history provides minimal predictive weight for insider decision-making at this specific ticker. The filing documents an open-market purchase by a director during a period of acute operational and financial stress, but the modest scale (4.0K shares) and absence of pattern context at GPGI warrant cautious assessment.

Director Kevin M Moriarty bought 13,000 shares of CMPO at $19.28 (250.6K); stock now at 52-week high, +34.3% in 30 days.

Director Moriarty acquired 13,000 shares at $19.28 on 2025-08-13, establishing an initial position in CompoSecure. The transaction occurs at the stock's 52-week high of $19.27, following a 34.3% gain over the prior 30 days and 52.8% gain over 90 days. CompoSecure remains unprofitable, with net income of $-26,125,000.00 over the most recent full fiscal year. The purchase represents a new position for Moriarty rather than an addition to existing holdings, and the timing coincides with the stock trading near its peak valuation range for the year.